References
- Yan L, Yu C, Zhao Z, Zhang Y, Wang R, Li C. Higher IL-9 level is associated with psoriasis vulgaris complicated by metabolic syndrome. Clin Cosmet Investig Dermatol. 2023;16:2297–2307. doi:10.2147/CCID.S422355
- Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA. 2020;323(19):1945–1960. doi:10.1001/jama.2020.4006
- Ovcina-Kurtovic N, Kasumagic-Halilovic E. Serum levels of tumor necrosis factor - alpha in patients with psoriasis. Mater Sociomed. 2022;34(1):40–43. doi:10.5455/msm.2022.33.40-43
- Gazel A, Rosdy M, Bertino B, Tornier C, Sahuc F, Blumenberg M. A characteristic subset of psoriasis-associated genes is induced by oncostatin-M in reconstituted epidermis. J Invest Dermatol. 2006;126(12):2647–2657. doi:10.1038/sj.jid.5700461
- Jung S, Lee SM, Suh D, Shin HT, Suh DC. The association of socioeconomic and clinical characteristics with health-related quality of life in patients with psoriasis: a cross-sectional study. Health Qual Life Outcomes. 2018;16(1):180. doi:10.1186/s12955-018-1007-7